Related Experiment Video

Updated: Sep 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Stroke prevention: is it possible? If so, which antihypertensive agent should be used?

Shokei Kim1

  • 1Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Current Medical Research and Opinion
|September 19, 2003
PubMed

Insights

Controlling blood pressure is vital for stroke prevention. Angiotensin receptor blockers (ARBs) show promise in preventing strokes and potential cognitive decline, possibly due to vascular protective effects beyond lowering blood pressure.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Effective blood pressure control is crucial for preventing strokes.
  • The optimal antihypertensive agents for stroke prevention remain unclear.
  • Stroke involves vascular remodeling, dysfunction, and cerebral circulation changes, suggesting a need for agents with direct vascular protective effects.

Purpose of the Study:

  • To evaluate the effectiveness of antihypertensive agents in stroke prevention.
  • To explore the potential of agents with direct vascular protective effects beyond blood pressure reduction.
  • To assess the role of angiotensin receptor blockers (ARBs) in stroke and cognitive decline prevention.

Main Methods:

  • Review of clinical trial evidence, including LIFE and SCOPE studies.
  • Analysis of findings from animal models investigating ARBs.
  • Evaluation of vascular protective effects of antihypertensive medications.

Main Results:

  • Clinical trials provide evidence supporting the importance of blood pressure control for stroke prevention.
  • Angiotensin receptor blockers (ARBs) have shown promising results in clinical trials.
  • Animal models suggest ARBs may offer benefits for stroke and cognitive decline prevention.

Conclusions:

  • Angiotensin receptor blockers (ARBs) represent a promising therapeutic option for stroke prevention.
  • ARBs may provide vascular protection beyond their blood pressure-lowering effects.
  • Further research into ARBs for stroke and cognitive decline prevention is warranted.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...